-

SAMHSA 42 CFR Part 2 vs HIPAA: 6 Hour Virtual Seminar on How to Apply Recent Changes - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "6-Hour Virtual Seminar on SAMHSA 42 CFR Part 2 vs HIPAA - How to Apply Recent Changes" webinar has been added to ResearchAndMarkets.com's offering.

The seminar will cover the latest SAMHSA and HIPAA updates which were released in January 2018 and December of 2017 respectively, and also cover multiple scenarios and FAQ's relating to Substance Abuse Records, Mental Health Records, Alcohol Abuse Records, and the proper ways to secure this information and/or release this information.

An overview of a comparative analysis will be presented comparing SAMHSA to the HIPAA laws relating to protected health information in general.

The lesson will be addressing how practice/business managers (or compliance offers) need to ensure their organization is complying with the Federal Substance Abuse and Mental Health Administration (SAMHSA) regulations (42 CFR Part 2) and how this differs from the HIPAA (Health Insurance Portability and Accountability Act) Privacy and Security Regulations.

Both regulations carry significant civil and even criminal penalties if not complied with. Both regulations are now being enforced proactively by the Federal government. Both regulations if not complied with can lead to catastrophic legal consequences on state laws of negligence and invasion of privacy if not complied with.

Benefits of Attending:

  • Is your organization working with substance abuse records? Join this 6-hour virtual seminar which will cover all the ins and outs of these two regulations and when to apply each one.
  • Are you aware of the strict federal regulations related to this type of sensitive information under the SAMHSA regulations?
  • Are you aware of the ramifications for non-compliance for both HIPAA and SAMHSA?
  • Are you clear on the differences between HIPAA and SAMHSA 42 CFR Part 2? - there are some small but extremely major differences that must be addressed between the two regulations.
  • The Substance Abuse and Mental Health Services Administration (SAMHSA) is the agency within the U.S. Department of Health and Human Services that leads public health efforts to advance the behavioral health of the nation.
  • SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities.

Key Topics Covered:

  • Updates for 2022
  • What is SAMHSA 42 CFR Part 2
  • What is HIPAA
  • Portable Devices
  • When and how records can be released
  • Proper Documentation Required
  • Enforcement of the Laws
  • SAMHSA vs HIPAA (specific scenarios)
  • Who must comply
  • Best Practices
  • Risk Factors for Breach
  • How to Avoid an Audit

For more information about this webinar visit https://www.researchandmarkets.com/r/44j9kw

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)" training has been added to ResearchAndMarkets.com's offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. Having appropriate CTAs in place is therefore essential for managing relationships between the diffe...

Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. Understand the regulatory frameworks governing drug/device and device/drug combinations in the European Union and the USA. The demarcation between medicinal products and devices is becoming ever more important and, with the conve...

Wedding Rings Market Trends, Shares and Growth Prospects 2025-2030 - Cultural and Social Trends Around Minimalism and Modern Design Drive Adoption of Non-Traditional Styles - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Wedding Rings - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Wedding Rings was valued at US$56.7 Billion in 2024 and is projected to reach US$80.7 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The wedding ring market is expanding due to a combin...
Back to Newsroom